Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes
about
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.Nucleic acid polymer REP 2139 and nucleos(t)ide analogues act synergistically against chronic hepadnaviral infection in vivo.
P2860
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@ast
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@en
type
label
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@ast
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@en
prefLabel
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@ast
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@en
P2093
P2860
P1433
P1476
Inhibition of hepatitis B vira ...... and primary human hepatocytes
@en
P2093
Andrew Vaillant
Camille Sureau
Françoise Berby
Isabelle Bordes
Matthieu Blanchet
Nora Martel
Olivier Hantz
P2860
P304
P356
10.1371/JOURNAL.PONE.0179697
P407
P577
2017-06-21T00:00:00Z